EFFECTIVENESS OF AMPICILLIN AGAINST GRAM-NEGATIVE BACTERIA. IN VITRO AND IN VIVO STUDIES OF A NEW ANTIBIOTIC.
D000667:Ampicillin; D000900:Anti-Bacterial Agents; D001431:Bacteriological Techniques; D002701:Chloramphenicol; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004754:Enterobacter; D004927:Escherichia coli Infections; D066298:In Vitro Techniques; D007612:Kanamycin; D007709:Klebsiella; D010400:Penicillin G; D010406:Penicillins; D010600:Pharmacology; D011113:Polymyxins; D011512:Proteus Infections; D011552:Pseudomonas Infections; D013307:Streptomycin; D013752:Tetracycline; D014552:Urinary Tract Infections
D000900:Anti-Bacterial Agents; D010406:Penicillins; D011113:Polymyxins; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D010400:Penicillin G; D013307:Streptomycin
AEROBACTER; AMPICILLIN; BACTERIOLOGICAL TECHNICS; CHLORAMPHENICOL; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI INFECTIONS; KANAMYCIN; KLEBSIELLA; PENICILLIN; PENICILLIN G; PHARMACOLOGY; POLYMYXIN; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; STREPTOMYCIN; TETRACYCLINE; URINARY TRACT INFECTIONS